NASDAQ:MDGL
Madrigal Pharmaceuticals
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.madrigalpharma.comipo date
Feb 06, 2007
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment ...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus